Operating Lease, Liability, Current of Intra-Cellular Therapies, Inc. from 31 Mar 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Intra-Cellular Therapies, Inc. quarterly Operating Lease, Liability, Current in USD history and change rate from 31 Mar 2019 to 31 Dec 2024.
  • Intra-Cellular Therapies, Inc. Operating Lease, Liability, Current for the quarter ending 31 Dec 2024 was $4,233,000, a 17% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Change (%)

Intra-Cellular Therapies, Inc. Quarterly Operating Lease, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $4,233,000 +$621,000 +17% 31 Dec 2024 10-K 21 Feb 2025 2024 FY
Q3 2024 $4,203,000 +$619,000 +17% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $4,171,000 +$613,000 +17% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $3,639,000 +$108,000 +3.1% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $3,612,000 -$955,000 -21% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $3,584,000 -$3,661,000 -51% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $3,558,000 -$4,185,000 -54% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $3,531,000 -$4,105,000 -54% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $4,567,000 -$2,165,000 -32% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $7,245,000 +$1,162,946 +19% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $7,743,000 +$2,147,943 +38% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $7,636,000 +$2,062,760 +37% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $6,732,000 +$1,190,198 +21% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $6,082,054 +$814,796 +15% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $5,595,057 +$1,621,137 +41% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $5,573,240 +$2,362,006 +74% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $5,541,802 +$2,354,367 +74% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $5,267,258 +$2,980,373 +130% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $3,973,920 +$1,710,943 +76% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $3,211,234 +$338,212 +12% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $3,187,435 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $2,286,885 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $2,262,977 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $2,873,022 31 Mar 2019 10-Q 08 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.